Farmacias Benavides, S.A.B. de C.V.
FBNVF
OTC PK
| 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | |
|---|---|---|---|---|---|
| Net Income | 14.59% | 3.02% | 16.04% | -44.66% | 13.87% |
| Total Depreciation and Amortization | 28.67% | 4.13% | -9.39% | -3.20% | 17.72% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 87.17% | 117.05% | -554.62% | 95.83% | -56.79% |
| Change in Net Operating Assets | -10.83% | -150.43% | 670.32% | 118.63% | 11.26% |
| Cash from Operations | 61.98% | 359.02% | -89.28% | 148.45% | -2.02% |
| Capital Expenditure | 77.69% | -45.23% | 43.32% | 36.94% | -- |
| Sale of Property, Plant, and Equipment | -16.91% | -38.83% | 101.01% | -70.74% | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -46.20% | 117.26% | -630.31% | -81.05% | 632.44% |
| Cash from Investing | 81.75% | -18.83% | 32.08% | 29.76% | -5,153.24% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -53.02% | -170.63% | 235.45% | -43.50% | 43.21% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -46.15% | -6.65% | -6.99% | -5.88% | 5.86% |
| Cash from Financing | -48.99% | -227.48% | 178.67% | -37.82% | 32.46% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 29.47% | -156.10% | 172.14% | 164.73% | 1.15% |
